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Summary Botulism in cattle is a rare but serious disease. In Germany there is no obliga-
tion to report botulism in animals and therefore a precise morbidity rate is not 
available. In this manuscript we describe an outbreak of Clostridium (C.) botuli-
num neurotoxin (BoNT) intoxication in a Saxony-Anhalt dairy cow stock of 286 
Holstein-Friesian cows and offspring in spring/summer 2009 and its diagnostic 
approach. 122 animals showed clinical signs of BoNT intoxication. 115 of the 
affected animals (40.2% of the herd) independent of age died or had to be eutha-
nized. Therapeutic attempts failed in almost all diseased cows, only four calves 
and three heifers recovered. Diagnostic samples of several animals (n = 4) (liver, 
ruminal and intestinal contents) and feed (n = 6) were tested for BoNT genes by 
polymerase chain reaction (PCR). BoNT gene type D was found in several 
(n = 8) organ samples. The PCR results allowed a preselection of samples for BoNT 
that were then tested by the mouse bioassay. Thus, the number of mice being 
inoculated in the mouse bioassay could be reduced. The mouse bioassay turned 
out positive (wasp-waist) in three preselected organ samples and the neutraliza-
tion test of one sample with type-specific antitoxin confirmed the presence of 
BoNT type D. We succeeded in isolating a C. botulinum strain from a liver sample 
which was typed as a D/C mosaic strain by sequence analysis of the toxin gene. 
However, the source of the BoNT intoxication could not be traced back.
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Zusammenfassung Botulismus bei Rindern ist eine seltene, aber schwerwiegende Erkrankung. In 
Deutschland besteht keine Melde- oder Anzeigepflicht für Botulismus, sodass 
keine Daten zur Erkrankungshäufigkeit verfügbar sind. Im vorliegenden Fallbe-
richt wird ein Botulismus-Ausbruch in einem Milchviehbetrieb in Sachsen-Anhalt 
beschrieben. Der Fall ereignete sich im Frühjahr/Sommer 2009 in einem Betrieb 
mit insgesamt 286 Holstein-Rindern. Bei 122 Tieren fielen klinische Anzeichen 
einer Intoxikation mit Clostridium (C.) botulinum Neurotoxin (BoNT) auf. 115 der 
klinisch erkennbar betroffenen Tiere (40,2 % des Bestandes) aller Altersgruppen 
verendeten oder mussten euthanasiert werden. Therapieversuche blieben meist 
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erfolglos, lediglich vier Kälber und drei Färsen erholten sich von der Erkrankung. 
Verschiedene Organproben von mehreren Tieren (n = 4) (Leber, Panseninhalt und 
Darminhalt) und Futtermittel (n = 6) wurden mittels Polymerase-Kettenreaktion 
(PCR) untersucht. BoNT Typ D Gensequenzen waren in mehreren Organproben 
(n = 8) nachweisbar. Diese Ergebnisse erlaubten eine Vorauswahl von Proben, die 
nachfolgend mit dem Maus-Bioassay untersucht wurden, wodurch die Anzahl der 
benötigten Versuchstiere reduziert werden konnte. Der Maus-Bioassay erbrachte 
bei den 3 vorausgewählten Proben einen positiven Neurotoxin-Nachweis (Wes-
pentaille). Der Neutralisationstest einer ausgewählten Probe mit typspezifischen 
Antitoxinen bestätigte die Anwesenheit von BoNT Typ D. Aus einer Leberprobe 
gelang die Isolierung eines C. botulinum-Stammes. Durch Sequenzierung des 
BoNT Gens konnte eine BoNT D/C Mosaikform des Toxin-Gens nachgewiesen 
werden. Die Eintragsquelle des Toxins konnte nicht ermittelt werden.
Schlüsselwörter: Botulismus, Rind, Clostridium botulinum type D/C, PCR, 
Maus-Bioassay
Introduction 
Botulism is a disease caused by Clostridium (C.) botu-
linum, a Gram-positive spore forming anaerobic bac-
terium which secretes a highly potent neurotoxin 
(Rossetto et al. 2014). C.  botulinum neurotoxin (BoNT) 
blocks the neurotransmitter release in peripheral nerve 
endings causing muscular paralyses. These neurotoxins 
and the corresponding C. botulinum isolate are character-
ised using a serotype system. Seven serotypes i. e. A, B, 
C, D, E, F and G are currently known, while a proposed 
novel serotype remains to be verified (Rossetto et al., 
2014). Botulism in cattle is most often caused by C. botu-
linum serotypes C and D. Clinical symptoms usually start 
after uptake of feed containing the toxin (Lindström et 
al., 2010). BoNT is absorbed via the intestines. It is then 
via the bloodstream transported to the neuromuscular 
junctions, where it inhibits the secretion of acetylcholine 
and generally leads to neuro-paralytic disease (Smith 
and Sugiyama, 1988). Clinical symptoms of botulism 
in cattle are depending on the dose and type of toxin 
ingested. Signs of botulism can dramatically vary from 
sudden death (animal collapse in a couple of hours) to 
slowly progressive paralysis with animals dying after 
days. Affected cattle often develop an unstable gait and 
eventually become recumbent. Typical symptoms are also 
cumulative chewing and swallowing disorders, profuse 
loss of saliva and a reduced tongue tonus which compli-
cates feed and water uptake (Braun, 2006). Paralysis of 
the diaphragm and the intercostal muscles causes aggra-
vated breathing and finally death. Paralysis progressing 
from cranial to caudal was described as well as paralysis 
starting at the hind legs (Braun, 2006; Haagsma, 1991). 
Caudal to cranial paralysis was described to start with 
instable movements, extended resting and difficulties to 
rise, followed by hind limb paralysis progressing to the 
forelegs, neck and head. A reduced tone of the tail can be 
remarkable. In the later course of the disease breathing 
difficulties, recumbency and finally death was observed. 
Some authors label this course of disease as atypical 
(Haagsma, 1991). A broad range of differential diagnoses 
has to be considered including infectious and metabolic 
diseases and toxaemia (Braun, 2006; Haagsma, 1991). 
Botulism is commonly diagnosed by proof of toxin from 
clinical samples, such as rumen or intestinal contents 
using the mouse bioassay (Lindström and Korkeala, 
2006). The mouse bioassay is still the standard diagnostic 
FIGURE 1: Cow showing clinical signs of sternal 
recumbency and hind limb weakness.
procedure for the detection of biologically active BoNT 
in clinical samples and the final proof for causality. The 
mouse bioassay is very sensitive and specific and allows 
the detection of any BoNT serotype in a wide variety 
of clinical samples (Dorner et al., 2013; Lindström and 
Korkeala, 2006). Depending on the protocol used for the 
detection of toxicity, a minimum of six animals per sam-
ple are needed, if serotyping is conducted another six 
animals will be required for each serotype (CDC, 1998; 
Solomon and Lilly, 2001; L06.00-26 [DIN 10102] of the 
official collection of analysis methods according to § 64 
of the German Food and Feed Code [LFGB]).
In this case report, we applied screening PCR to reduce 
the number of animals required in the current standard 
test, the mouse bioassay. C. botulinum neurotoxin type D 
was shown to be the cause of disease.
Case description and diagnostic 
procedures 
Case description
In May 2009 various animals of a dairy cow stock in Sax-
ony-Anhalt (Germany) with 286 Holstein cows and off-
spring showed clinical signs of a paralytic disease, thus C. 
botulinum intoxication was suspected. The first dead ani-
mal was noticed on May 12th. Cases occurred in a slightly 
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biphasic manner (Fig. 2) till end of June, with a decrease 
at the end of May and beginning of June. 115 of 122 
diseased cows (40.2% of the stock) died or had to be 
euthanized. Age distribution and numbers of affected 
animals are listed in Table 1. Death of cows in late gravidity 
happened almost always shortly after being dried off. 
Deaths of cows in early stage of lactation were noticed 
in the later course of the events. Therapeutic attempts 
(see subsequent paragraph) failed in all cows and only 
four calves and three heifers recovered. Affected cows 
showed progressive caudal to cranial paralysis, starting 
with hind limb ataxia which in severe cases deteriorated 
to recumbency (Fig. 1). Additionally, laboured breath-
ing, ataxia, staggered rising and a reduced tongue tonus 
were observed. In the majority of cases, consciousness, 
appetite as well as food intake seemed undisturbed. 
Approximately 5% of all cases showed a peracute course 
of disease with animals developing sudden recumbency 
after the last milking with a normal milk yield or sud-
den death without clinical signs. About 10% of all cases 
showed slow progression with clinical signs developing 
over ten to 14 days with final recumbency. Calves and 
heifers showed the same clinical signs and comparable 
development of disease, but in acute cases a fast pro-
gressing cachexia was additionally noted. Approximately 
40% of the affected calves (four of eight) and heifers 
(three of nine) recovered even after some of them having 
been recumbent for one up to 14 days.
Therapeutic approach
Animals were treated symptomatically with parenteral 
administration of fluids and anti-inflammatory drugs. 
Vaccination of all animals with C. botulinum vaccine 
(Botulism vaccine for cattle, horses, mules, sheep and 
goats, Onderstepoort Biological Products SOC Ltd, 
Onderstepoort, South Africa) was applied according to 
the manufacturers‘ instructions. After the first applica-
tion on day 45 of the outbreak (Fig. 2) no more clinical 
cases occurred. The second vaccination was adminis-
tered 36 days later.
Sample collection
Mid-May, four cattle cadavers were directed to the 
pathology laboratory of the Saxony-Anhalt State Office 
for Consumer Protection, Department 4 – Veterinary 
Medicine, Stendal for gross pathology. Organ mate-
rial (ruminal content, intestinal content, liver) and feed 
stuff (feed 1–5: milking cows’ mixed ration, maize grain 
silage, sugar-beet pressed pulps, wilted grass silage, 
maize silage) were passed on to the Institute of Bacterial 
Infection and Zoonoses, Friedrich-Loeffler-Institut (FLI), 
Federal Research Institute for Animal Health, Jena. 
In an attempt to identify the source of intoxication, 
one month after testing the samples mentioned above, a 
farm visit was undertaken and further samples were col-
lected including feed (feed 6: maize grain silage), water, 
a pigeon corpse, pigeon faeces (pigeons were present 
at the farm and in the stables at higher numbers) and 
chicken faeces (a poultry farm was located nearby the 
affected stables). The precise numbers and sort of sam-
ples investigated are shown in Table 3.
Mouse bioassay
To prepare the extract for the mouse bioassay, 80 g of each 
sample was mixed with an equal volume (80 ml) of gela-
tine-phosphate buffer (2 g gelatine, 4 g disodium hydro-
gen phosphate, 1000 ml aqua dest., pH = 6,2 ± 0,1) using 
a Stomacher® 400 circulator (250 rpm, 1 min; Seward Ltd., 
Worthing, UK). An exception was made concerning wilted 
grass silage, wherefore only 40 g were mixed with 80 ml 
of gelatine-phosphate buffer. This preparation was incu-
bated in a refrigerator overnight at 4°C. The liquid content 
was transferred to a centrifuge tube (Nalgene; Thermo 
Fisher Scientific Inc. Waltham, MA., USA) and centrifuged 
for 20 min at 10 000 rcf (xg) at 4°C (Biofuge 22R-Heraeus, 
Offenbach, Germany). The maintained supernatant was 
then filtered (0.22 μm syringe filter, Sartorius, Göttingen, 
Germany) to ensure sterility.
The resulting extract was tested for the presence of 
botulinum neurotoxin by the mouse bioassay. Adult 
male and female BALB/c mice (18–25  g) were used in 
FIGURE 2: Course 
of the outbreak of 
botulism in cattle.  
The blue columns 
show the number of 
dead animals each 
day. Day 1 is the start 
of the outbreak when 
the first dead animal 
was noticed. The 
red arrows indicate 
vaccination. After the 
first application on 
day 45 of the outbreak 
the second vaccination 
was administered  
36 days later.
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the mouse bioassay. The mouse bioassay and treatment 
of extracts followed method L06.00-26 (DIN 10102) 
of the official collection of analysis methods according 
to §  64 of the German Food and Feed Code (LFGB). 
Boiled extracts (100°C for ten min) were used as control 
samples. Trypsin treated extracts, diluted 1:2 in gela-
tine-phosphate buffer containing 1% trypsin (Trypsin 
(1:250), powder, Life Technologies GmbH, Darmstadt, 
Germany), and the non-trypsin treated extracts, diluted 
1:2 in gelatine-phosphate buffer, were prepared. Two 
mice were injected with 0.5 ml of each extract (extract, 
trypsin treated extract, heated extract), respectively, to 
determine toxicity. Trypsin treated samples were omit-
ted in the mouse bioassay, if the proteolytic activation of 
BoNT was not required (i. e. for type C and D) (Cook et 
al., 1998; Lindström and Korkeala, 2006).
Toxin typing by neutralization assay was performed 
with type specific monovalent antitoxin sera type A to 
F (CIDC Lelystad, NL) according to method L06.00-26. 
Where appropriate, antisera were pooled for the mouse 
bioassay, i.  e. as BoNT type D gene was detected by 
PCR, non-relevant antisera types A, B, E and F were 
pooled. Mice were observed for four days. The extract 
dilutions 1:2, 1:20 and 1:200 of the caecum sample of 
cow 2 were subjected to the neutralization mouse bio-
assay. One group of mice (n = 6) received the extract 
without antiserum, another group received the extract 
including the pooled antisera type A, B, E and F, the next 
group received the extract including antiserum type C 
and the last group received the extract including antise-
rum type D. The mouse bioassay was performed accord-
ing to the German Animal Welfare Act with permission 
of the respective authorities (Thuringia, State Office for 
Consumer Protection, reg. no. 22-2684-04-04-104/07).
DNA extraction 
DNA extraction of each sample was performed from 
the overnight extraction mixture (80  g sample plus 
80  ml gelatine-phosphate buffer) for the mouse bio-
assay before it was centrifuged. 1.5  ml of the mixed 
sample was removed and centrifuged at 8000  g for 
ten min. The resulting pellet was used for DNA extrac-
tion with DNeasy Blood and Tissue Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s protocol for 
Gram positive bacteria. 
For DNA extraction after an enrichment step, each 
sample was additionally brought in liquid culture 
medium and incubated anaerobic at 37°C for 6–11 days. 
A total of either 1 g of sample material or 2 g of mixed 
sample (see above) was inoculated into 10 ml of either 
reinforced clostridial medium (RCM, Oxoid, Wesel, Ger-
many) or modified cooked meat medium containing 
1.5  g meat particles (cooked meat medium, Oxoid, 
Wesel, Germany) and 15 ml nutrient solution containing 
7.8 g casein peptone, 7.8 g meat peptone, 1.0 g glucose, 
2.8  g yeast extract, 1.0  g soluble starch, 5.6  g sodium 
chloride per litre. Then 1.5 ml was removed and centri-
fuged at 8000 g for 10 min. The resulting pellet was used 
for DNA extraction with DNeasy Blood and Tissue Kit 
(Qiagen, Hilden, Germany) as described.
BoNT gene PCR
Detection of C. botulinum type C and D neurotoxin (BoNT 
type C and D) genes was done by single PCR described 
elsewhere (Takeshi et al., 1996). Briefly, oligonucleotide 
primers (MWG Eurofins, Ebersberg, Germany) for the 
detection of BoNT type C and D genes were used as 
described (Takeshi et al., 1996). BoNT type C primer 
CS-11: 5´-ATA CAC TAG CTA ATG AGC CTG-3´ and 
CS-22: 5´-TGG AGT ATT GTT ATT CCC AGG-3´. BoNT 
type D primer DS-11: 5´-GTG ATC CTG TTA ATG ACA 
ATG-3´ and DS-22: 5´-TCC TTG CAA TGT AAG GGA 
TGC-3´ amplification products are 290 bp for BoNT type 
C gene and 497 bp for BoNT type D gene. A total of 25 µl 
PCR reaction volume was used, a reaction contained 
5 pmol of each primer, 250 µM dNTP mix, 1 mM MgCl2, 
1x PCR Buffer (Qiagen, Hilden, Germany), 1x Q-Solution 
(Qiagen, Hilden, Germany), 1.25  U HotStarTaq DNA 
Polymerase (Qiagen, Hilden, Germany). Amplification 
was carried out in a thermal cycler (Mastercycler, Eppen-
dorf AG, Eppendorf, Germany). PCR reaction was sub-
jected to the following conditions: initial denaturation for 
15 min at 95°C; 35 cycles of denaturation (15 sec at 95°C), 
annealing (one  min at 55°C), extension (one  min at 
72°C); and a final extension at 72°C for 3 min. PCR prod-
ucts were separated by electrophoresis in a 1.5% agarose 
gel, stained with ethidium bromide, visualized with UV 
illumination at 312 nm and finally photo documented. 
Isolation of C. botulinum 
One cm³ of a PCR BoNT type D gene positive liver 
sample was kept in methylated spirit for five days and 
then streaked out on egg-yolk agar plates (Columbia 
Agar Base (Oxoid, Wesel, Germany) containing 10% Egg 
Yolk Emulsion (Oxoid), 1% Lactose and 1% of a 0,4% 
Bromocresol purple solution (Merck, Darmstadt Ger-
many) which were previously stored under anaerobic 
conditions. The plates were incubated at 37°C for 24 to 
48 h under anaerobic conditions. Single colonies show-
ing a mother-of-pearl layer and optionally a precipita-
tion zone were subsequently subcultured and tested for 
BoNT type D gene by PCR (Takeshi et al., 1996).
Sequence analysis of the toxin gene 
For sequence analysis, five PCR primer pairs were 
designed generating overlapping fragments (Tab.  2). 
Primer sequences were derived from BoNT type D/C 
chimeric sequence GenBank Accession number D38442.1 
(Moriishi et al., 1996). A total of 50  µl PCR reaction 
volume was used, a reaction contained 10 pmol of each 
primer, 250 µM dNTP mix, 1.5 mM MgCl2, 1x PCR Buffer 
(Qiagen, Hilden, Germany), 1.25  U HotStarTaq DNA 
Polymerase (Qiagen, Hilden, Germany). Amplification 
was carried out in a thermal cycler (Mastercycler, Eppen-
dorf AG, Eppendorf, Germany). PCR reaction was sub-
jected to the following conditions: initial denaturation for 
15 min at 95°C; 35 cycles of denaturation (1 min at 95°C), 
annealing (1 min at 50°C), extension (1 min at 72°C); and 
final extension at 72°C for 2 min. PCR products were sep-
arated by electrophoresis in a 1.5% agarose gel, stained 
with ethidium bromide, visualized with UV illumination 
at 312 nm and finally photo documented. PCR products 
were purified using High Pure PCR Product Purification 
Kit (Roche Diagnostics GmbH, Mannheim, Germany) 
according to the manufacturer’s instructions. The PCR 
products were sequenced by cycle sequencing (Eurofins 
Genomics GmbH, Ebersberg, Germany) using both, for-
ward and reverse primers. Sequences obtained from both 
runs were aligned, primer sequences were removed and 
reading mistakes were corrected. For obtaining the whole 
toxin gene sequence, overlapping sequences were aligned 
using Geneious version 8.0.5. (Kearse et al., 2012).
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samples in the mouse bioassay (Tab. 3). All extracts inves-
tigated tested toxic to mice, toxicity signs detected were 
indicative for BoNT. The corresponding heated extracts 
used as negative-controls tested non-toxic. Based on 
the PCR (BoNT type D gene) and the respective mouse 
bioassay results, it was decided to test one sample in the 
neutralization assay. 
For this purpose the caecum sample of cow 2 was 
selected, whose extract dilutions including the pooled 
antisera A, B, E and F and extract dilutions including 
the antiserum C tested toxic. All mice receiving extract 
dilutions including the antiserum type D survived and 
showed no symptoms. 
C. botulinum was isolated from liver tissue of cow 4 
(Tab.  3). The isolate tested positive for BoNT type D 
gene by PCR (Takeshi et al., 1996). Subsequent initial 
sequencing of the BoNT gene resulted in an incomplete 
BoNT type D/C chimeric sequence (Data not shown). 
Sequencing was repeated using primers derived from 
an available BoNT type D/C sequence (GenBank Acces-
sion number D38442.1) (Tab. 2). We were able to obtain 
a 3879 bp sequence containing the complete coding 
sequence of a chimeric BoNT type D/C gene (Accession 
number KT025245).
Discussion
Our cumulative data give evidence that the disease caus-
ing the death of 40.2% of the dairy cow stock on the 
affected farm was caused by C. botulinum intoxication. 
This report is an example for a possible strategy for labo-
ratory diagnosis of a botulism outbreak using a combi-
nation of PCR and mouse bioassay in order to reduce the 
number of mice needed for definite diagnosis. Basically, 
the preliminary clinical diagnosis and gross pathology 
suggested botulism. Our focus was to examine selected 
animal samples to confirm the clinical diagnosis and to 
identify the BoNT serotype. Feed and environmental 
samples were analysed to possibly trace back the source 
of this botulism outbreak.
The first therapeutic approach in suspected botulism 
would be the administration of polyvalent antitoxin as 
soon as possible because it is effective only against circu-
lating toxin and not effective when the toxin has reached 
the neuromuscular junction and entered the nerve termi-
nus (Anniballi et al., 2013). However, polyvalent antitoxin 
usually produced for use in humans is very expensive 
and not available for the treatment of cattle botulism. 
Furthermore, these polyvalent sera formulations usually 
do not contain antitoxin type C and D. Consequently, the 
initial therapeutic approach was not to use anti-toxin but 
concentrated on supporting measures against metabolic 
stress and stabilisation of metabolism. Also anti-inflam-
matory drugs were administered. However, reduced water 
and food intake must be addressed therapeutically when 
it is observed. Vaccination is commonly used as a preven-
tive measure in areas where botulism is endemic. It is also 
considered an effective approach in outbreak situations 
(Anniballi et al., 2013). We decided to apply vaccina-
tion as no source of intoxication could be found and the 
outbreak continued. Vaccination had to be permitted by 
the local health authorities because no commercial vac-
cine is licensed in Germany. Appropriate diagnosis of 
the serotype is required for the selection of the vaccine. 
A vaccine (Botulism Vaccine, Onderstepoort Biological 
Results
C. botulinum neurotoxin detection was performed on 
animal and feed samples from a Saxony-Anhalt dairy 
cow stock. In this herd the reported clinical picture i. e. 
paralysis and no specific gross pathological findings was 
highly suspicious for botulism but the initial examination 
of samples of cow 1 showed no toxicity in the mouse bio-
assay. Five days later, samples from cow 2, 3, 4 and feed 
samples 1–5 arrived at the FLI. The feed samples were 
immediately prepared for the mouse bioassay to possibly 
identify a toxin source but no toxicity was detected. In the 
further diagnostic procedures we investigated the envi-
ronmental and feed samples by PCR to preselect samples 
and to avoid additional mouse bioassays (Tab. 3).
PCR investigation of organ samples of cow 1 was 
performed. A DNA extract from a small intestine sample 
of cow 1 tested positive for BoNT type D gene (Tab. 3). 
Samples from liver and rumen content as well as the 
enriched samples of gut, liver and rumen contents tested 
negative for BoNT type C and D genes (Tab. 3). Also 
direct extraction based PCRs as well as enrichment cul-
ture based PCRs of feed samples 1–5 tested negative for 
BoNT type C and D genes. All environmental samples 
tested negative in the PCR assay (Tab. 3).
In order to rapidly select samples for the mouse bioas-
say, PCR was performed on DNA samples from cows 2, 
3 and 4 omitting a pre-enrichment step. BoNT type D 
gene DNA was detected in the caecum samples of cow 
2 and 3 and in a liver sample of cow 4 (Tab. 3). Based on 
these results it was decided to test the three PCR positive 
TABLE 1: Overview of the number of affected animals 
(diseased and perished/euthanized) according to their age 
cohort and stock number
Age cohort Stock  
number
(11.05.2009)




Calves 69 8 4 (5,8)
Young cattle/heifers 18 9 6 (33,3)
Cows (early lactation) 25 21 21 (84)
Cows (later lactation) 143 72 72 (50,3)
Cows (dried off, phase 1)* 6 10 10 (100*)
Cows (dried off, phase 2) 25 2 2 (8)
Total number 286 122 115 (40,2)
* Cows of the later lactation group changed to the dried off phase I group, morta-
lity rate cannot exceed 100%
TABLE 2: Sequencing primers used to determine the nucleo-
tide sequence of the BoNT gene of the outbreak isolate. Primer 
sequences were selected according to GenBank Accession number 
D38442.1 strain „South African” (Moriishi et al., 1996)





R1 5´-GAAGTGGTCCAAATATCAAT-3´ 630–649 528
F2 5´-AGTTTGAAAATGGTAGTTGG-3´ 581–600
R2 5´-CAAATCTACTACACTTTCTGA-3´ 1438–1458 877
F3 5´-TAATATAGAAAATTCGGGTCAG-3´ 1380–1401
R3 5´-GATAACTTATATGATTAAATTGAGT-3´ 2302–2326 946
F4 5´-GAGTTAAGAGATGGAAAGATT-3´ 2240–2260
R4 5´-CATCATATTGGTAGTAATAGTTA-3´ 3179–3201 961
F5 5´-AGTGAACAAGATATAAACTTTAGT-3´ 3109–3132
R5 5´-TTTAACATAATTTATACTATTACTTATT-3´ 4022–4049 940
bp = basepairs
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Products SOC Ltd, Onderstepoort, 
South Africa) which contains type C 
and type D toxoid was used. Finally 
we cannot state whether the vac-
cination had an influence on the 
termination of the outbreak at all 
or if simply the toxin uptake ceased 
e. g. contaminated feed was totally 
consumed. Still we would recom-
mend emergency vaccination and 
if possible replacement of feedstuff.
Laboratory diagnosis of botu-
lism is challenging because of the 
extraordinary toxic potency and 
variability of BoNT. Despite a vari-
ety of promising developments in 
detection technologies for BoNT 
e.  g by so called Endopep MS 
(Dorner et al., 2013; Kalb et al., 
2015; Singh et al., 2013) the mouse 
bioassay still is the standard diag-
nostic procedure for the detection 
of biologically active BoNT in clini-
cal samples and the final proof for 
causality (Dorner et al., 2013; Lind-
ström and Korkeala, 2006; Singh 
et al., 2013). Initially, samples from 
one animal reached the laboratory 
and were immediately investigated 
for the presence of BoNT. Unfortu-
nately, the performed mouse bio-
assay failed to detect toxins in the 
tested samples. Similar findings 
were reported in former botulism 
outbreaks, where it was difficult to detect BoNT at all 
(Abbitt et al., 1984; Sharpe et al., 2008; Trueman et al., 
1992). A negative mouse bioassay does not exclude botu-
lism, because toxin may not be present in the selected 
samples at a detectable level. Therefore, more samples 
have to be tested. We decided to primarily screen the 
majority of samples by PCR and to follow up only those 
showing a positive PCR result. That pre-selection of sam-
ples facilitated a significant reduction of mice required to 
perform the mouse bioassay. Additionally, trypsin treated 
samples were omitted in the mouse bioassay because 
the proteolytic activation of BoNT type D in samples is 
not required (Cook et al., 1998; Lindström and Korkeala, 
2006), which allowed a further saving of mice. Our modi-
fied protocol allowed us to test three samples using four 
mice each instead of nine samples (organ samples of cow 
2, 3, and 4) with six mice each, saving 42 mice compared 
to the standard protocol. The mouse bioassay tested 
positive (wasp-waist) in all organ samples chosen. The 
neutralization test with type D specific antitoxin of one 
selected sample confirmed the presence of BoNT type D. 
Cross neutralization effects with type C specific antitoxin 
were not observed. In summary, the approach specified 
above effected a saving of mice, time and money.
The PCR used for detection of BoNT genes (Takeshi 
et al., 1996) targets a conserved region within the first 
third of the coding sequence. Sequence analysis revealed 
sequence similarity to a chimeric form of BoNT type D/C 
genes previously described to cause botulism in cattle in 
Japan (Nakamura et al., 2010) and in Europe (Woudstra 
et al., 2012). These BoNT D/C types are highly repre-
sented among European bovine isolates (Woudstra et al., 
2012). Indeed, this is the first case report of mosaic gene 
BoNT type D/C cattle botulism in Germany. The chimeric 
form of BoNT type D/C was completely neutralized by 
type D antiserum. In contrast the antitoxin type C did 
not protect the mice; similar findings were previously 
reported (Nakamura et al., 2010). Historic underreport-
ing of chimeric BoNT type D/C in cattle seems well 
probable. 
Environmental contamination might be a source for 
the described botulism outbreak. Type C botulism in 
cattle has been previously reported in association with 
a botulism outbreak in wild waterfowl (Wobeser et al., 
1997). Silage contaminated with poultry carcasses caused 
botulism in cattle (Hogg et al., 1990). Water was also 
implicated in botulism outbreaks (Jean et al., 1995; Swift 
et al., 2000; Wobeser et al., 1997). Even though we were 
not able to trace back the outbreak, we cannot exclude an 
environmental source of the botulism intoxication. Simi-
lar results were previously reported, where even with the 
mouse bioassay no BoNT was detected in the animal and 
feed samples at a dairy farm in the Republic of Ireland, 
although the history, clinical signs and post-mortem 
examination strongly suggested botulism (Sharpe et al., 
2008). Moreover various botulism outbreaks in England 
and Wales were associated with poultry litter despite the 
source remained unknown because routine examination 
of broiler litter and feed were not undertaken (Payne et 
al., 2011).
The source of the botulinum neurotoxin intoxication of 
the dairy cow stock could not be identified but close local 
and organizational connection to poultry was present, 
which is considered a risk factor (Payne et al., 2011). 
TABLE 3: Comparison of results of toxin gene detection by PCR using DNA 
extractions from samples (direct extraction) and DNA extractions from enrichment 
culture and the results of detection of toxicity and toxin typing by mouse bioassay
Sample Number PCR Mouse bioassay
direct extraction enrichment culture toxicity typing
type C type D type C type D
Cow 1 rumen 1 neg. neg. neg. neg. neg. -
small intestine 1 neg. pos. neg. neg. neg. -
liver 1 neg. neg. neg. neg. neg. -
Cow 2 rumen 1 neg. neg. - pos. - -
caecum 1 neg. pos. - pos. pos. type D
liver 1 neg. neg. - neg. - -
Cow 3 rumen 1 neg. neg. - pos. - -
caecum 1 neg. pos. - pos. pos. -
liver 1 neg. neg. - pos. - -
Cow 4 rumen 1 neg. neg. - pos. - -
caecum 1 neg. neg. - neg. - -
liver 1 neg. pos. - pos. pos. -
Feed 1 milking cows mixed 
ration
1 neg. neg. - neg. neg. -
Feed 2 maize grain silage 1 neg. neg. - neg. neg. -
Feed 3 pressed sugar beet 
pulps
1 neg. neg. - neg. neg. -
Feed 4 wilted grass silage 1 neg. neg. - neg. neg. -
Feed 5 maize silage 1 neg. neg. - neg. neg. -
Feed 6 maize grain silage 2 neg. neg. neg. neg. - -
Water 1 neg. neg. neg. neg. - -
Pigeon faeces 5 neg. neg. neg. neg. - -
Pigeon small intestine 1 neg. neg. neg. neg. - -
Pigeon caecum 1 neg. neg. neg. neg. - -
Pigeon colon 1 neg. neg. neg. neg. - -
Chicken faeces 1 neg. neg. neg. neg. - -
pos. = positive
neg. = negative
- = not investigated
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